A breakthrough combination in the realm of cancer therapy has emerged, being the merging of the strength of aspirin with the specific treatment of osimertinib.This innovative approach has sparked a revived interest in the probability, which is the mixing of these two drugs to combat different types of cancer.in our article, we will investigate the reason for the combination, investigate the probability benefits, and discuss the difficulties that lie ahead.The understanding of the working principle behind aspirin osimertinib is the first demand.A NSAID (NSAID), aspirin, has been widely used, being…
